Biomarkers to Predict the Response to Pembrolizumab in Chinese NSCLC Patients
Clinical trial NCT04076228 · COMPLETED
Trial details
- NCT number
- NCT04076228
- Sponsor
- Kiang Wu Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.